P Lukas
Overview
Explore the profile of P Lukas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
516
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arnold C, Lindner A, Schachtner G, Tulchiner G, Tulchiner N, Mangesius J, et al.
Strahlenther Onkol
. 2021 Aug;
198(1):25-32.
PMID: 34414475
Purpose: Treatment of muscle-invasive bladder cancer (MIBC) remains challenging, especially for elderly and/or comorbid patients. Patients who are unfit for or refuse surgery should receive bladder-preserving multimodality treatment (BPMT), consisting...
2.
Oertel M, Elsayad K, Engenhart-Cabillic R, Reinartz G, Baues C, Schmidberger H, et al.
Strahlenther Onkol
. 2020 Oct;
196(12):1096-1102.
PMID: 33125504
Purpose: The coronavirus pandemic is affecting global health systems, endangering daily patient care. Hemato-oncological patients are particularly vulnerable to infection, requiring decisive recommendations on treatment and triage. The aim of...
3.
Cavalier E, Lukas P, Bottani M, Aarsand A, Ceriotti F, Coskun A, et al.
Osteoporos Int
. 2020 Apr;
31(8):1461-1470.
PMID: 32270253
Introduction: Within-subject (CV) and between-subject (CV) biological variation (BV) estimates are essential in determining both analytical performance specifications (APS) and reference change values (RCV). Previously published estimates of BV for...
4.
Kriz J, Baues C, Engenhart-Cabillic R, Haverkamp U, Herfarth K, Lukas P, et al.
Strahlenther Onkol
. 2016 Sep;
193(2):100-108.
PMID: 27678010
Introduction: Field design changed substantially from extended-field RT (EF-RT) to involved-field RT (IF-RT) and now to involved-node RT (IN-RT) and involved-site RT (IS-RT) as well as treatment techniques in radiotherapy...
5.
Kriz J, Baues C, Engenhart-Cabillic R, Haverkamp U, Herfart K, Lukas P, et al.
Strahlenther Onkol
. 2016 Sep;
193(2):109-115.
PMID: 27596217
Introduction: As part of the foundation of the German Hodgkin Study Group (GHSG) in 1978, a central radiotherapy (RT) reference centre was established to evaluate and to improve the quality...
6.
Ott O, Strnad V, Potter R, Hammer J, Hildebrandt G, Resch A, et al.
Strahlenther Onkol
. 2016 May;
180 Suppl 1:109-28.
PMID: 27137924
No abstract available.
7.
Wendt T, Gademann G, Pambor C, von Specht H, Martin T, Baltas D, et al.
Strahlenther Onkol
. 2016 May;
180 Suppl 1:5-87.
PMID: 27137922
No abstract available.
8.
Hubalek M, Bartsch R, Gnant M, Kapp K, Lang A, Lax S, et al.
Geburtshilfe Frauenheilkd
. 2014 Oct;
72(4):293-298.
PMID: 25284834
The prognosis of breast cancer is most heavily influenced by the status of the axillary nodes. Until a few years ago, this knowledge was gained through radical axillary lymph node...
9.
Skvortsov S, Dudas J, Eichberger P, Witsch-Baumgartner M, Loeffler-Ragg J, Pritz C, et al.
Br J Cancer
. 2014 May;
110(11):2677-87.
PMID: 24786604
Background: In order to improve therapy for HNSCC patients, novel methods to predict and combat local and/or distant tumour relapses are urgently needed. This study has been dedicated to the...
10.
Seeber A, Mitterer M, Gunsilius E, Mazzoleni G, Giovannetti R, Farsad M, et al.
Oncology
. 2013 Jan;
84(3):186-90.
PMID: 23328311
Objective: Treatment of lung cancer patients is changing rapidly and new treatment options have emerged in recent years. In 2007, to guarantee the best treatment procedure for lung cancer patients...